These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27049530)

  • 1. 3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors.
    Fang Y; Lu Y; Zang X; Wu T; Qi X; Pan S; Xu X
    Sci Rep; 2016 Apr; 6():23634. PubMed ID: 27049530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of flavonoids on their anti-Escherichia coli activity and inhibition of DNA gyrase.
    Wu T; Zang X; He M; Pan S; Xu X
    J Agric Food Chem; 2013 Aug; 61(34):8185-90. PubMed ID: 23926942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P56(lck) kinase inhibitor studies: a 3D QSAR approach towards designing new drugs from flavonoid derivatives.
    Gunda SK; Narasimha SK; Shaik M
    Int J Comput Biol Drug Des; 2014; 7(2-3):278-94. PubMed ID: 24878734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structure-activity relationship study of flavonoids as inhibitors of E. coli by membrane interaction effect.
    Wu T; He M; Zang X; Zhou Y; Qiu T; Pan S; Xu X
    Biochim Biophys Acta; 2013 Nov; 1828(11):2751-6. PubMed ID: 23938956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR (CoMFA and CoMSIA) and pharmacophore (GALAHAD) studies on the differential inhibition of aldose reductase by flavonoid compounds.
    Caballero J
    J Mol Graph Model; 2010 Nov; 29(3):363-71. PubMed ID: 20863730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzoflavonoids Structure Hinders Human Colon Cancer Clonogenicity.
    Yong Y; Koh EJ; Ahn S; Kim BS; Lee YH; Shin SY; Lim Y
    Med Chem; 2017; 13(2):168-175. PubMed ID: 27220561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
    Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ
    SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of (quinolin-4-ylthio)carboxylic acids as new Escherichia coli DNA gyrase B inhibitors: machine learning studies, molecular docking, synthesis and biological testing.
    Metelytsia L; Hodyna D; Dobrodub I; Semenyuta I; Zavhorodnii M; Blagodatny V; Kovalishyn V; Brazhko O
    Comput Biol Chem; 2020 Apr; 85():107224. PubMed ID: 32018168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D QSAR CoMFA/CoMSIA and docking studies on azole dione derivatives, as anti-cancer inhibitors.
    Anugolu RK; Gunda SK; Mahmood S
    Int J Comput Biol Drug Des; 2012; 5(2):111-36. PubMed ID: 22854121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors.
    Azam MA; Thathan J
    SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining molecular docking and QSAR studies for modelling the antigyrase activity of cyclothialidine derivatives.
    Saíz-Urra L; Cabrera Pérez MÁ; Helguera AM; Froeyen M
    Eur J Med Chem; 2011 Jul; 46(7):2736-47. PubMed ID: 21530019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of methicillin resistance staphylococcus aureus inhibitors through 3D-QSAR, molecular docking and molecular dynamics simulations.
    Ballu S; Itteboina R; Sivan SK; Manga V
    Comput Biol Chem; 2018 Apr; 73():95-104. PubMed ID: 29475176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An explorative study on potent Gram-negative specific LpxC inhibitors: CoMFA, CoMSIA, HQSAR and molecular docking.
    Shiri F; Salahinejad M; Dijoor R; Nejati-Yazdinejad M
    J Recept Signal Transduct Res; 2018 Apr; 38(2):151-165. PubMed ID: 29623756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
    Awasthi M; Singh S; Pandey VP; Dwivedi UN
    J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies.
    Thaimattam R; Daga P; Rajjak SA; Banerjee R; Iqbal J
    Bioorg Med Chem; 2004 Dec; 12(24):6415-25. PubMed ID: 15556759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
    Sethi KK; Verma SM
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
    Sainy J; Sharma R
    SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined QSAR/QSPR and molecular docking study on fluoroquinolones to reduce biological enrichment.
    Zhao X; Zhao Y; Ren Z; Li Y
    Comput Biol Chem; 2019 Apr; 79():177-184. PubMed ID: 30836319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids as CDK1 Inhibitors: Insights in Their Binding Orientations and Structure-Activity Relationship.
    Navarro-Retamal C; Caballero J
    PLoS One; 2016; 11(8):e0161111. PubMed ID: 27517610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.